Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 153 No. 11 (2023)

Haemoglobin thresholds for transfusion: how are we doing in the era of Choosing Wisely? A retrospective cohort study

  • Phyranavy Jeganathan-Udayakumar
  • Nicole Tochtermann
  • Thomas Beck
  • Maria M. Wertli
  • Christine Baumgartner
DOI
https://doi.org/10.57187/smw.2023.40132
Cite this as:
Swiss Med Wkly. 2023;153:40132
Published
29.11.2023

Summary

INTRODUCTION: Clinical practice guidelines and the Choosing Wisely initiative launched in 2012 recommend a haemoglobin (Hb) threshold of 70–80 g/lfor red blood cell (RBC) transfusions in stable hospitalised patients. Data on transfusion practices and their trends in medical inpatients are limited. To address this gap, we investigated transfusion practices and their trends in general internal medicine and other clinics.

METHODS: This retrospective cohort study analysed data from all hospitalisations with RBC transfusions at a Swiss university hospital between 2012 and 2019. We included all first transfusion episodes if pretransfusion Hb was available. The primary endpoint was mean pretransfusion Hb; secondary endpoints included potentially inadequate transfusions (i.e., transfusions at Hb ≥80 g/l) and receipt of a single RBC unit. Trends in mean pretransfusion Hb over time were estimated using generalised estimating equations, and risk factors for potentially inadequate transfusions were identified using multivariable adjusted generalised estimating equations models.

RESULTS: Of 14,598 hospitalisations with RBC transfusions, 1980 (13.6%) were discharged from general internal medicine. From 2012 to 2019, mean pretransfusion Hb decreased from 74.0 g/l to 68.8 g/l in general internal medicine (mean annual decrease –0.76 g/l, 95% confidence interval [CI] –0.51 to –1.02) and from 78.2 g/l to 72.7 g/l in other clinics (mean annual decrease –0.69, 95% CI –0.62 to –0.77; p for interaction 0.53). The overall proportion of potentially inadequate transfusions was 17.8% in general internal medicine and 24.1% in other clinics (p <0.001) and decreased over the study period from 26.9% to 5.5% in general internal medicine and from 37.0% to 15.2% in other clinics. In contrast, the proportion of cases receiving a single RBC unit increased (39.5% to 81.4% in general internal medicine, 42.7% to 66.1% in other clinics). Older age (adjusted odds ratio [aOR] 1.45, 95% CI 1.32–1.58 for ≥65 vs <65 years), having surgery (aOR 1.24, 95% CI 1.14–1.36), acute haemorrhage (aOR 1.16, 95% CI 1.02–1.33), chronic heart failure (aOR 1.17, 95% CI 1.04–1.32), ischaemic heart diseases (aOR 1.27, 95% CI 1.15–1.41), chronic pulmonary diseases (aOR 1.24, 95% CI 1.08–1.42), malignancy (aOR 1.11, 95% CI 1.01–1.21), and rheumatic disease (aOR 1.27, 95% CI 1.01–1.59) were risk factors for potentially inadequate transfusions.

CONCLUSIONS: More restrictive transfusion practices were adopted in general internal medicine and other clinics over time, suggesting that guideline recommendations and the Choosing Wisely initiative may have been increasingly followed. Interventions to reduce potentially inadequate transfusions should target providers who care for older patients and those with surgery or chronic cardiac and pulmonary diseases.

References

  1. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016 Nov;316(19):2025–35. 10.1001/jama.2016.9185 DOI: https://doi.org/10.1001/jama.2016.9185
  2. Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Physician. 2011 Mar;83(6):719–24.
  3. Blood transfusion safety - World Health Organization. September 21, 2021]; Available from: https://www.who.int/health-topics/blood-transfusion-safety/
  4. Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective. Blood. 2008 Oct;112(7):2617–26. 10.1182/blood-2008-07-077370 DOI: https://doi.org/10.1182/blood-2008-07-077370
  5. de Bruin S, Scheeren TW, Bakker J, van Bruggen R, Vlaar AP; Cardiovascular Dynamics Section and Transfusion Guideline Task Force of the ESICM. Transfusion practice in the non-bleeding critically ill: an international online survey-the TRACE survey. Crit Care. 2019 Sep;23(1):309. 10.1186/s13054-019-2591-6 DOI: https://doi.org/10.1186/s13054-019-2591-6
  6. Soril LJ, Noseworthy TW, Stelfox HT, Zygun DA, Clement FM. A retrospective observational analysis of red blood cell transfusion practices in stable, non-bleeding adult patients admitted to nine medical-surgical intensive care units. J Intensive Care. 2019 Apr;7(1):19. 10.1186/s40560-019-0375-3 DOI: https://doi.org/10.1186/s40560-019-0375-3
  7. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion. 2010 Apr;50(4):753–65. 10.1111/j.1537-2995.2009.02518.x DOI: https://doi.org/10.1111/j.1537-2995.2009.02518.x
  8. Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA. 2014 Apr;311(13):1317–26. 10.1001/jama.2014.2726 DOI: https://doi.org/10.1001/jama.2014.2726
  9. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ. 2015 Mar;350 mar24 9:h1354. 10.1136/bmj.h1354 DOI: https://doi.org/10.1136/bmj.h1354
  10. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999 Feb;340(6):409–17. 10.1056/NEJM199902113400601 DOI: https://doi.org/10.1056/NEJM199902113400601
  11. Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021 Dec;12(12):CD002042. DOI: https://doi.org/10.1002/14651858.CD002042.pub5
  12. Wisely C. American Association of Blood Banks. Five Things Physicians and Patients Should Question. [December 6, 2022]; Available from https://www.choosingwisely.org/societies/american-association-of-blood-banks/
  13. Murphy MF, Wallington TB, Kelsey P, Boulton F, Bruce M, Cohen H, et al.; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusions. Br J Haematol. 2001 Apr;113(1):24–31. 10.1046/j.1365-2141.2001.02701.x
  14. Smarter Medicine. Stationäre Allgemeine Innere Medizin. [December 6, 2022]; Available from https://www.smartermedicine.ch/de/top-5-listen/stationaere-allgemeine-innere-medizin-2016
  15. Rahimi-Levene N, Ziv-Baran T, Peer V, Golik A, Kornberg A, Zeidenstein R, et al. Hemoglobin transfusion trigger in an internal medicine department - A “real world” six year experience. PLoS One. 2018 Mar;13(3):e0193873. 10.1371/journal.pone.0193873 DOI: https://doi.org/10.1371/journal.pone.0193873
  16. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al.; FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011 Dec;365(26):2453–62. 10.1056/NEJMoa1012452 DOI: https://doi.org/10.1056/NEJMoa1012452
  17. Vincent JL, Jaschinski U, Wittebole X, Lefrant JY, Jakob SM, Almekhlafi GA, et al.; ICON Investigators. Worldwide audit of blood transfusion practice in critically ill patients. Crit Care. 2018 Apr;22(1):102. 10.1186/s13054-018-2018-9 DOI: https://doi.org/10.1186/s13054-018-2018-9
  18. von Babo M, Chmiel C, Müggler SA, Rakusa J, Schuppli C, Meier P, et al. Transfusion practice in anemic, non-bleeding patients: cross-sectional survey of physicians working in general internal medicine teaching hospitals in Switzerland. PLoS One. 2018 Jan;13(1):e0191752. 10.1371/journal.pone.0191752 DOI: https://doi.org/10.1371/journal.pone.0191752
  19. Schweizerische Operationsklassifikation (CHOP), Systematisches Verzeichnis – Version 2020 April 3, 2021]; Available from: https://www.bfs.admin.ch/bfs/de/home/statistiken/kataloge-datenbanken/publikationen.assetdetail.9286150.html
  20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. 10.1016/0021-9681(87)90171-8 DOI: https://doi.org/10.1016/0021-9681(87)90171-8
  21. Docherty AB, O’Donnell R, Brunskill S, Trivella M, Doree C, Holst L, et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis. BMJ. 2016 Mar;352:i1351. 10.1136/bmj.i1351 DOI: https://doi.org/10.1136/bmj.i1351
  22. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al.; TRISS Trial Group; Scandinavian Critical Care Trials Group. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014 Oct;371(15):1381–91. 10.1056/NEJMoa1406617
  23. Blood transfusion. NICE guideline. [December 6, 2022]; Available at https://www.nice.org.uk/guidance/ng24/resources/blood-transfusion-pdf-1837331897029
  24. Vlaar AP, Oczkowski S, de Bruin S, Wijnberge M, Antonelli M, Aubron C, et al. Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med. 2020 Apr;46(4):673–96. 10.1007/s00134-019-05884-8 DOI: https://doi.org/10.1007/s00134-019-05884-8
  25. Netzer G, Liu X, Harris AD, Edelman BB, Hess JR, Shanholtz C, et al. Transfusion practice in the intensive care unit: a 10-year analysis. Transfusion. 2010 Oct;50(10):2125–34. 10.1111/j.1537-2995.2010.02721.x DOI: https://doi.org/10.1111/j.1537-2995.2010.02721.x
  26. Surial B, Burkhart A, Terliesner N, Morgenthaler M, Bächli E. Adherence to transfusion guidelines: are we prepared for the Smarter Medicine or Choosing Wisely initiative? Swiss Med Wkly. 2015 Jan;145:w14084. 10.4414/smw.2015.14084 DOI: https://doi.org/10.4414/smw.2015.14084
  27. Goel R, Chappidi MR, Patel EU, Ness PM, Cushing MM, Frank SM, et al. Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014. JAMA. 2018 Feb;319(8):825–7. 10.1001/jama.2017.20121 DOI: https://doi.org/10.1001/jama.2017.20121
  28. Roubinian NH, Murphy EL, Mark DG, Triulzi DJ, Carson JL, Lee C, et al. Long-Term Outcomes Among Patients Discharged From the Hospital With Moderate Anemia: A Retrospective Cohort Study. Ann Intern Med. 2019 Jan;170(2):81–9. 10.7326/M17-3253 DOI: https://doi.org/10.7326/M17-3253
  29. Patient Blood Management am Kleinspital - Swiss Medical Forum. [July 9, 2023]; Available from https://medicalforum.ch/de/detail/doi/smf.2020.08505
  30. Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, et al.; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III). Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion. 2014 Oct;54(10 Pt 2):2678–86. 10.1111/trf.12825 DOI: https://doi.org/10.1111/trf.12825
  31. Swissmedic, Haemovigilance Jahresbericht 2020, July 2020. [December 6, 2022]; Available from https://www.swissmedic.ch/swissmedic/de/home/humanarzneimittel/marktueberwachung/haemovigilance/haemovigilance-publications-events/haemovigilance-report-2020.html
  32. Baron RJ, Lynch TJ, Rand K. Lessons From the Choosing Wisely Campaign’s 10 Years of Addressing Overuse in Health Care. JAMA Health Forum. 2022 Jun;3(6):e221629. 10.1001/jamahealthforum.2022.1629 DOI: https://doi.org/10.1001/jamahealthforum.2022.1629
  33. Meybohm P, Richards T, Isbister J, Hofmann A, Shander A, Goodnough LT, et al. Patient Blood Management Bundles to Facilitate Implementation. Transfus Med Rev. 2017 Jan;31(1):62–71. 10.1016/j.tmrv.2016.05.012 DOI: https://doi.org/10.1016/j.tmrv.2016.05.012
  34. Verdecchia NM, Wisniewski MK, Waters JH, Triulzi DJ, Alarcon LH, Yazer MH. Changes in blood product utilization in a seven-hospital system after the implementation of a patient blood management program: A 9-year follow-up. Hematology. 2016 Sep;21(8):490–9. 10.1080/10245332.2015.1112496 DOI: https://doi.org/10.1080/10245332.2015.1112496
  35. Seitz KP, Sevransky JE, Martin GS, Roback JD, Murphy DJ. Evaluation of RBC Transfusion Practice in Adult ICUs and the Effect of Restrictive Transfusion Protocols on Routine Care. Crit Care Med. 2017 Feb;45(2):271–81. 10.1097/CCM.0000000000002077 DOI: https://doi.org/10.1097/CCM.0000000000002077
  36. Sadana D, Kummangal B, Moghekar A, Banerjee K, Kaur S, Balasubramanian S, et al. Adherence to blood product transfusion guidelines-An observational study of the current transfusion practice in a medical intensive care unit. Transfus Med. 2021 Aug;31(4):227–35. 10.1111/tme.12771 DOI: https://doi.org/10.1111/tme.12771
  37. Peyrony O, Gamelon D, Brune R, Chauvin A, Ghazali DA, Yordanov Y, et al. Red Blood Cell Transfusion in the Emergency Department: An Observational Cross-Sectional Multicenter Study. J Clin Med. 2021 Jun;10(11):2475. 10.3390/jcm10112475 DOI: https://doi.org/10.3390/jcm10112475
  38. Patient blood management in hematology and oncology. [July 9, 2023]; Available at https://www.aabb.org/docs/default-source/default-document-library/resources/pbm-in-hematology-and-oncology.pdf?sfvrsn=21725df9_2
  39. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999 Oct;282(15):1458–65. 10.1001/jama.282.15.1458 DOI: https://doi.org/10.1001/jama.282.15.1458
  40. Watson P, Watson D, Dhesi A, New HV, Davidson A, Armstrong R, et al. Improving blood-prescribing decisions: evaluating the efficacy of a blood guidelines app. Transfus Med. 2020 Dec;30(6):485–91. 10.1111/tme.12736 DOI: https://doi.org/10.1111/tme.12736
  41. Zuckerberg GS, Scott AV, Wasey JO, Wick EC, Pawlik TM, Ness PM, et al. Efficacy of education followed by computerized provider order entry with clinician decision support to reduce red blood cell utilization. Transfusion. 2015 Jul;55(7):1628–36. 10.1111/trf.13003 DOI: https://doi.org/10.1111/trf.13003
  42. Rothschild JM, McGurk S, Honour M, Lu L, McClendon AA, Srivastava P, et al. Assessment of education and computerized decision support interventions for improving transfusion practice. Transfusion. 2007 Feb;47(2):228–39. 10.1111/j.1537-2995.2007.01093.x DOI: https://doi.org/10.1111/j.1537-2995.2007.01093.x
  43. Delaforce A, Duff J, Munday J, Hardy J. Overcoming barriers to evidence-based patient blood management: a restricted review. Implement Sci. 2020 Jan;15(1):6. 10.1186/s13012-020-0965-4 DOI: https://doi.org/10.1186/s13012-020-0965-4
  44. Garrioch M, Sandbach J, Pirie E, Morrison A, Todd A, Green R. Reducing red cell transfusion by audit, education and a new guideline in a large teaching hospital. Transfus Med. 2004 Feb;14(1):25–31. 10.1111/j.0958-7578.2004.00476.x DOI: https://doi.org/10.1111/j.0958-7578.2004.00476.x
  45. Tinmouth A, Macdougall L, Fergusson D, Amin M, Graham ID, Hebert PC, et al. Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians’ transfusion practices. Arch Intern Med. 2005 Apr;165(8):845–52. 10.1001/archinte.165.8.845 DOI: https://doi.org/10.1001/archinte.165.8.845
  46. Hubbard AE, Ahern J, Fleischer NL, Van der Laan M, Lippman SA, Jewell N, et al. To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology. 2010 Jul;21(4):467–74. 10.1097/EDE.0b013e3181caeb90 DOI: https://doi.org/10.1097/EDE.0b013e3181caeb90

Most read articles by the same author(s)